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Summary 
We show that the adhesion of T lymphoid cells to immobilized fibronectin  can be increased 
by two distinct mechanisms. The first is by increasing the affinity of the fibronectin receptor/ligand 
interaction using the antiq~l integrin monodonal antibody 8A2. The second is by treating the 
ceUs with phorbol 12-myristate 13-acetate (PMA), which alters events that occur after receptor 
occupancy (e.g.,  cell spreading)  without affecting receptor  affinity. The effects of these two 
mechanisms on adhesion in the presence of physiological concentrations of soluble fibronectin 
suggest that they have different biological consequences. Under these conditions, the net effect 
of increasing the affinity of the fibronectin  receptors is to decrease cell adhesion, whereas the 
increase in adhesion induced by PMA is unaffected. This suggests that the high affinity receptors 
are not primarily available for cell adhesion under these circumstances, and that they have an 
alternative function. We further show that high affinity binding of soluble fibronectin  can be 
induced by either differentiation  of the monocytic cell line THP-1 or by cross-linking  the T 
cell receptor complexes on the T lymphoid cell line HUT-78. The differentiated monocytic cells 
express two populations  of fibronectin  receptors:  a minority in a high affinity state, and the 
majority in a low affinity state. Thus they will both continue to adhere in the presence of 
physiological  concentrations of soluble fibronectin and bind significant  amounts of soluble fibronectin 
at the cell surface. 
T  lymphocytes and monocytes need to adhere to extracel- 
lular matrix molecules such as fibronectin, collagen, and 
laminin during migration into sites of inflammation, and these 
interactions are mediated by members of the integrin family 
of adhesion receptors (1, 2). The principal fibronectin receptors 
expressed by peripheral blood mononuclear cells are c~4fll 
and c~5fll (3), and both are implicated in the migration of 
lymphoid cells into sites of inflammation (4, 5) and beneath 
bone marrow-derived stromal cells in culture (6). otSfll recog- 
nizes  the  central  cell-binding domain of fibronectin  (7), 
whereas  o~4fll binds  to the alternatively  spliced V region 
(8-12). The minimal sequence identified for binding to this 
region is leucine-aspartic acid-valine (12, 13). c~4fll also recog- 
nizes the cell surface receptor vascular cell adhesion molecule 
1 (VCAM-1)  (14). 
Fibronectin is a prominent adhesive ligand that exists in 
both soluble and insoluble  forms (15). Soluble fibronectin 
is a disulfide linked dimer, ~,440 kD, that is present  in all 
body fluids, including plasma (concentration 450-900 nM), 
amniotic fluid, bronchoalveolar lavage fluid, synovial fluid, 
and pleural effusions (15). Insoluble fibronectin  multimers 
are formed by certain cells in culture, resulting in a fibriUar 
matrix at the cell surface (16, 17). Integrin c~5131 is required 
for assembly of this matrix (18-20). A similar fibrillar ma- 
trix of fibronectin is in stromal or reticular connective tissue, 
in basement  membranes,  around muscle fibers, and in the 
walls of blood vessels (15). 
The affinity of the integrins for soluble ligands is highly 
regulated.  This  has been demonstrated in ligand binding 
studies with odlbB3 (21-24), c~MB2 (25) and oe5/31 (26, 27). 
The increase in affinity of ot5~1 for soluble fibronectin was 
induced by the anti-131 monodonal antibody 8A2 (28), which 
is one of a group of antibodies that increase/31-mediated cel- 
lular adhesion to immobilized ligands (29-31). Other means 
of stimulating/31-mediated adhesion have also been described, 
including cell stimulation with phorbol esters or by cross- 
linking a variety of cell surface receptors (32-38).  However, 
these  studies  did not directly measure  the affinity of the 
receptor-ligand  interaction, and so it is uncertain whether 
the increase in adhesion is due to changes in affinity or due 
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(e.g.,  cell spreading).  Similar stimuli and monoclonal anti- 
bodies also promote ~2-mediated cell aggregation or adhe- 
sion to immobilized ligands (39-46). 
In this paper we examine how regulation of integrin func- 
tion impacts on the adhesion of T lymphocytes and mono- 
cytes to fibronectin. The adhesion to fibronectin mediated 
by integrins o~4B1 and ot5B1 could be affected by either al- 
tering the receptors' affanity  for fibronectin or by altering events 
that follow ligand binding, and the presence of soluble fibro- 
nectin has dramatically different effects on cell adhesion in- 
duced by these two mechanisms. In addition, we have studied 
two physiological mechanisms for inducing high affinity 
fibronectin binding. The frst is the differentiation of mono- 
cytic cells, where we find that the number of high affinity 
fibronectin receptors expressed by the differentiated cells con- 
stitutes only a minority of the total number of fibronectin 
receptors  on the cell surface. The second mechanism for in- 
ducing high affinity fibronectin binding is by cross-linking 
the TCR complex on T  lymphoid cells. 
Materials  and  Methods 
Antibodies andgeagents.  Production,  characterization,  and puri- 
fication of the routine anti-human ~1 monoclonal antibody 8A2 
(IgG1-K isotype) has been described (27, 28). The concentration 
of purified IgG was determined by absorbance at 280 nM (10D 
= 0.8 mg/ml) (47). The rat anti-human 0~5 monodonal antibody 
Ab 16 (20) was used at a concentration of 20/zg/ml. The routine 
anti-human or4 monodonal antibody HP2/1 (48) was used as a 
1:10 dilution of tissue culture supematant. The murine anti-CD3 
monoclonal  antibody  cell  line OKT3 was purchased from the Amer- 
ican Type Culture Collection (ATCC; Rockville, MD) and the an- 
tibody used as purified  IgG. Phorbo112-myristate  13-acetate (PMA) 
and cytochalasin D were purchased from Sigma Chemical Com- 
pany (St. Louis, MO). 
Cells.  The T lymphoid cell lines Molt-4 and HUT-78 were pur- 
chased from the ATCC, and were maintained in RPMI medium 
(Biowhittaker  Inc., Walkersvilh,  ME)) supplemented  with 10% FCS 
(Biowhittaker  Inc.), 1% glutamine, and 1% penicillin  and 1% strep- 
tomycin (both from Sigma Chemical Co.). The monocytic cell line 
THP-1 was purchased from the ATCC, and maintained in the same 
medium with the addition of 20 mM 2-ME (Sigma  Chemical Co.). 
Human T lymphocytes were purified from the peripheral blood 
of  normal donors by centrifugation  on a Ficoll-Paque  gradient (Phar- 
macia LKB, Piscataway, NJ), panning for monocytes on serum- 
coated dishes, and passaging over a nylon wool column (49). 
Stimulation of Cells.  Cells  were incubated with the indicated 
concentrations of PMA or 8A2 for the duration of the assays (30 
rain). THP-1 cells were differentiated by the addition of 100 nM 
of  PMA to the culture medium for 48 h before the assays. HUT-78 
ceils were stimulated by cross-linking their TCR with OKT3 IgG 
(10/~g/ml) for 5 min at 22~  followed  by mixing with the cross- 
linking antibody (affinity  isohted polyclonal  goat anti-mouse IgG 
[1/~g/ml; Sigma  Chemical  Co.]) for the 30-rain duration of  the assay. 
Flow Cytometry.  Cells  were washed twice at 4~  with buffer 
(PBS, pH 7.4, plus 1% FCS and 0.02% sodium azide), resuspended 
at 10  x  106 cells/ml, and 50/zl incubated with the same volume 
of primary antibody for 20 rain at 4~  The cells were washed 
once in excess cold buffer, and incubated with a 1:200 dilution of 
secondary antibody (FITC-labeled goat anti-mouse IgG or FITC- 
labeled goat anti-rat IgG, Tago, Inc., Burlingame, CA) for 20 min 
at 4~  in the dark. Background fluorescence  was determined by 
incubating an aliquot of  cells with secondary  antibody alone. After 
a further wash in excess cold buffer, the cells were resuspended in 
500 ~1 of  the same  buffer and analyzed  immediately  on a FACScan  | 
(Becton Dickinson & Co., Mountain View, CA), using the Lysis 
II program. To determine the effect of the 8A2 antibody on the 
expression of c~5 on differentiated THP-1, one aliquot of the cells 
was also incubated with Ab16 plus 100 nM of 8A2 Fab fragments 
(27), followed by the FITC-labeled goat anti-rat secondary anti- 
body. The expression  with and without 8A2 was analyzed  as above, 
and the result expressed as a mean fluorescence  index where the 
background fluorescence  was normalized to a value of 1. 
Purification of  Human Fibronectin.  Fibronectin was isolated  from 
fresh human citrated plasma  by affinity  chromatography  on gelatin- 
Sepharose (Pharmacia  LKB), as previously  described (27). The iso- 
lated fibronectin yielded a single band on SDS-PAGE under non- 
reducing conditions, and a closely spaced doublet of 215,000 and 
230,000 daltons under reducing conditions, consistent with the 
reported properties of plasma fibronectin (50). The concentration 
of fibronectin was determined by absorbance at 280 nM (1 mg/ml 
=  OD  1.3) (27). 
Radiolabeling of Fibronectin.  The fibronectin was labeled with 
12sI by a modified Chloramine-T procedure, as previously  described 
(27). Greater than 90% of the radioactivity was precipitated by 
10% trichloroacetic acid, and the radiolabeling does not alter the 
affinity of fibronectin binding to an integrin (23), Aliquots were 
stored at  -70~  after the addition of BSA to 1% final concen- 
tration. 
Binding Assays.  The binding  of 12SI-labeled fibronectin was 
performed as previously described (27). The standard buffer used 
in the assays  was modified Tyrode's  buffer (150 mM NaC1, 2.5 mM 
KC1, 12 mM NaHCO3,  1 mg/ml BSA, 1 mg/ml glucose, and 2 
mM MgCI2), pH 7.4, and the incubation time was 30 min at 
37~  A typical binding assay, performed in a 1.5-ml microcen- 
trifuge tube (Sarstedt, Germany), was in a 200/~1 vol composed 
of 120 #1 of cells (2  x  106/tube), 40 #1 of radiolabeled fibronectin, 
and 40 #1 of  stimuhs (8A2 or PMA) and/or inhibitor (EDTA, excess 
cold fibronectin, or monoclonal antibody). After the incubation, 
50-#1 aliquots were layered in triplicate onto 300 #1 of 20% su- 
crose in the same buffer in microfuge tubes (West Coast Scientific 
Inc., Hayward, CA), and centrifuged for 3 min at 12,000 rpm in 
a microfuge  (model 11; Beckman  Instruments, Fullerton, CA). The 
tips were amputated and counted, and the bound protein was cal- 
culated from the specific  activity of the ligand (assuming a molec- 
ular weight for fibronectin  of  440,000 daltons). The residual  bound 
radioactivity in the presence of either 50x  excess  cold fibronectin 
or 5 mM EDTA was subtracted as nonspecific  binding. The data 
was fitted to equilibrium binding models using the LIGAND pro- 
gram (51). 
Assays of Cell Adhesion to Immobilized Fibronectin.  Cell adhe- 
sion to immobilized fibronectin was quantified as previously de- 
scribed (27). Fibronectin (50/zl/well) at the concentrations indi- 
cated in the  text was coated onto a 96-well Immulon  II plate 
(Dynatech Laboratories, Inc., ChantiUy, VA) for 2 h at 37~  and 
then the wells were blocked with 1% BSA in PBS for I h at 37~ 
The buffer used in the adhesion  assay  was the same as in the binding 
assays. In the assays  using soluble fibronectin the ceils were prein- 
cubated with 8A2 or PMA and soluble fibronectin for 30 rain at 
room temperature, before addition to the wells. Where indicated, 
cells were preincubated with cytochalasin  D for 30 min at 37~ 
At the commencement of the assay the cells (concentration 106 
cells/ml) were added to the wells in 100-#1 aliquots with appro- 
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antibody). After a 30-rain incubation at 37~  the nonadherent 
cells were washed offwith 3 rounds of  gentle pipetting.  The residual 
adherent cells were checked by visual  inspection, and quantified 
with a colorimetric reaction using endogenous cellular acid phos- 
phatase activity (52). Optical densities  were determined using an 
ELISA plate reader (Molecular Devices Corp., Menlo Park,  CA) 
with a 410-nM filter. Background values, determined in wells coated 
with 1% BSA alone, were subtracted from each point. Adherence 
was expressed as a percentage of  the number of  cells originally added 
to each well, and determined from a standard curve generated using 
known numbers of cells. 
Photograpl~  Peripheral blood T lymphocytes were purified and 
allowed  to attach to the bottom of microtitre wells coated with 
fibronectin (concentration 5 #g/ml) for 30 rain at 37~  Before 
washing they were photographed at 200 x  magnification using an 
inverted phase contrast microscope (model CK-2, Olympus, Tokyo, 
Japan)  with a Polaroid  camera attachment. 
Results 
PMA and the Anti-~l Monoclonal Antibod2/ 8A2 Stimulate 
T Cell Adhesion to Fibronectin by Different Mechanisms.  To in- 
vestigate the regulation of T lymphoid cell adhesion to fibro- 
nectin we first studied the cell line Molt-4. The fibronectin 
receptors expressed by these cells are c~4/31 and ol5~1, and 
their relative levels on the cell surface as determined by flow 
cytometry were comparable to those on peripheral blood T 
lymphocytes (Fig. t). Molt-4 cells adhered slightly to fibro- 
nectin, and both PMA and antibody 8A2 induced a dose- 
dependent increase in the adhesion (Fig. 2 a). Similar effects 
were observed with purified peripheral blood T lymphocytes 
(not shown). Basal and stimulated adhesion were both de- 
pendent on the presence of bound fibronectin and completdy 
inhibited by a combination of blocking monoclonal antibodies 
directed against ot4B1 and a5~1, as previously described (28). 
To investigate the mechanism of increased adhesion we mea- 
sured the effect of these stimuli on the af~nity of soluble 
fibronectin binding. Surprisingly, PMA failed to stimulate 
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Figure 2.  PMA induces Molt-4 adhesion to immobilized fibronectin 
without increasing the affinity of binding of soluble fibronectin. (a) The 
effect of  increasing concentrations  of  PMA and 8A2 on adhesion  of  Molt-4 
cells to fibronectin (2.5 #g/ml) was determined as described in Materials 
and Methods. The results are expressed as the percentage of  the cells added 
to each well that remain adherent after washing, and are the mean _+ SD 
of  three determinations. (b) The effect of  the same concentrations  of  PMA 
and 8A2 on the binding of lzSI-labeled soluble fibronectin to Molt-4 cells 
was determined as described in Materials and Methods. The results shown 
are the estimated specific  binding, and are the mean _+ SD of three deter- 
minations. 
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Figure  1.  Flow cytometric analysis of the expres- 
sion of  integrin r  (using HP2/1) and o~5 (using Ab16) 
chains by purified peripheral blood T lymphocytes, 
Molt-4 cells, HUT-78 ceils, THP-1 cells, and THP-1 
cells after 48 h of differentiation with PMA. Flow 
cytometry  was performed as described  in the Materials 
and Methods. 
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T lymphocytes on immobilized fibronectin. Human peripheral blood T 
lymphocytes were isolated as described in Materials and Methods, and al- 
lowed to adhere to immobilized  fibronectin (5/~g/ml) for 30 min at 37~ 
in the absence of stimulus (a), or in the presence of PMA (b) or 8A2 (c). 
The cells were photographed using an inverted phase contrast microscope 
(CK-2; Olympus, Tokyo, Japan) with a Polaroid camera attachment. 
the binding of fibronectin to the cells (Fig. 2 b). In contrast, 
8A2 induced a dose-dependent  increase in the binding of 
12SI-labeled soluble fibronectin  to Moh-4 ceUs. 
Since PMA increased the adhesion of the Moh-4 calls to 
fibronectin without affecting the affinity of the receptors for 
the ligand, we sought alternative explanations for the PMA 
effect. In phase contrast microscopy the cells stimulated with 
PMA underwent a marked spreading on fibronectin,  while 
unstimulated ceils or those stimulated with 8A2 remained 
predominantly rounded up on fibronectin.  This was most 
dearly seen with purified peripheral blood T  lymphocytes 
(Fig. 3), where by 30 min the majority (;>65%) of the calls 
stimulated  with PMA were well spread whereas <10% of 
the unstimulated and 8A2 stimulated cells were spread. Thus, 
PMA promotes a dramatic alteration in the shape of these 
lymphoid ceils. 
To test the possibility that PICA promotion of adhesion 
of  lymphoid cells  was associated  with cell spreading, we treated 
the calls with cytochalasin D,  Pretreating Moh-4 cells for 
30 rain with 1/~M cytochalasin D blocked ceil spreading, 
and basal adhesion was inhibited  (from 19  _+  5 to 0%  of 
the cells). Further, the capacity of PICA to stimulate adhe- 
sion was abrogated (Fig. 4). Nevertheless, the 8A2 antibody 
still induced increased adhesion. 
Based on the foregoing results, PMA and 8A2 appear to 
exert their effects on different steps in the adhesion process. 
To test this hypothesis, we examined their combined effect 
on adhesion. In the presence of  limiting amounts of  immobi- 
lized fibronectin, the combination of maximal doses of  PMA 
and 8A2 increased adhesion more effectively  than either alone 
(Fig. 5). The combination of 8A2 and PMA had no greater 
effect on the binding of soluble fibronectin than 8A2 alone 
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Figure  4.  Cytochalasin  D pretreatment of Molt-4 cells selectively  in- 
hibits PMAinduced  adhesion  to immobi]ized  fibmnectin.  Cells were  prein- 
cubated with cytochalasin  D (1/~M) for 30 rain at 37~  and then the 
effects  of PMA (20 riM) and 8A2 (20 riM) on adhesion  to fibronectin  (2.5 
/~g/ml)  determined  as described  in Materials  and Methods.  In the absence 
of stimulus 19 •  5% of the ceils  remained  adherent  without cytochalasin 
D, and 0% of the cells remained  after cytochalasin  D pretreatment. The 
results are expressed as the number of ceils adherent  above the basal level 
of adhesion, and are the mean _+ SD of three determinations. 
e~ 
.o 
ca 
.c 
~J 
60" 
50" 
40" 
30' 
20' 
[]  no stimulus 
[]  +PMA 
[]  +8A2 
10' 
0  ........ 
no soluble fibronecfin  +  soluble fibronectin 
Figure 6.  PMA and 8/i2 have opposite effects  on adhesion of Molt-4 
cells to immobilized  fibronectin  in the presence of a physiological  concen- 
tration of soluble  fibronectin.  Ceils  were  preincubated  for 30 rain at 37~ 
with PMA (20 nM), 8A2 (20 nM), or neither, and with or without 750 
nM soluble  fibronectin.  Adhesion  to immobilized  fibronectin  (2.5 #g/ml) 
was then determined  as described  in Materials and Methods. The results 
are expressed as the percentage  of the ceils added to each  well  that remain 
adherent after  washing,  and are the mean •  SD of three determinations. 
(3308  +  321 fibronectin molecules bound per call with both 
vs. 3296  +_  71 with 8A2 alone). 
PMA and 8t12 Have Opposite Effects on Adhesion in the Pres- 
ence of Physiological Concentrations of Sohble Fibronectin.  In 
the foregoing experiments we characterized  two mechanisms 
of promoting cell adhesion to fibronectin. PMA increased 
adhesion by altering cell shape, whereas 8A2 increased  the 
af~nity of the receptors  for the fibronectin. We next inves- 
tigated the biological implications of these alternative mech- 
anisms by performing the adhesion assay in the presence of 
a physiological plasma concentration of soluble fibronectin 
(750 riM) (Fig. 6). In the absence of soluble fibronectin, PMA 
induced a fourfold (11-43%) increase in adhesion and 8A2 
induced a threefold increase (to 30%). Addition of soluble 
fibronectin profoundly altered the adhesion response to 8A2. 
Under these conditions, 8A2 inhibited adhesion (7-1%). In 
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Figure 5.  PMA and 8A2 have  additive  effects  on the adhesion  of Molt-4 
cells to immobilized  fibronectin. Adhesion  of Molt-4 calls to increasing 
concentrations  of  fibronectin  in the absence  of  stimuhs, or in the presence 
of PMA (20 nM), 8A2 (20 riM), or both together  was determined  as de- 
scribed in Materials and Methods. 
contrast, PMA stimulation still resulted in a fourfold enhance- 
ment of adhesion (7-29%). 
Physiologic Modulation of the Affinity of cr5~l,  The fore- 
going experiment suggested that high af~nity fibronectin 
receptors do not promote adhesion to immobilized fibronectin 
in the presence of  physiologic concentrations of soluble fibro- 
nectin. To gain insight into the potential functions of high 
af~nity receptors, we assessed the physiological circumstances 
in which they were induced. 
We first studied the monocytic  cell line THP-1, which takes 
on a number of  macrophage-like characteristics when induced 
to differentiate by treatment with phorbol esters  (53,  54). 
These include changing from a suspension to an adherent 
phenotype in culture, with a moderate degree of spreading. 
THP-1 cells express approxirnatdy equal amounts of cx4131 
and c~5~1, and the relative amounts did not significantly 
change with differentiation (Fig.  1).  Adhesion of the calls 
to fibronectin was blocked by a combination of antibodies 
directed against these two receptors  (not shown). 
Undifferentiated THP-1  cells bound soluble fibronectin 
with low a~inity (Ka  =  919 nM),  and the addition of a 
saturating concentration of 8A2 IgG (20 riM) resulted in an 
,vS0-fold higher fibronectin binding affinity (Kd  =  18.2 
nM) (not shown). The binding of soluble fibronectin was 
almost completely dependent on o~5~1, as an antibody directed 
against this receptor (Ab 16) inhibited binding by •90%, 
whereas an anti-c~4~l monoclonal antibody (HP2/1) had little 
effect (Fig. 7 a). In other experiments, we found that Ramos 
B lymphoid cells, which express c~4B1 and not ol5~1,  did 
not bind fibronectin with high ~fl~nity  in physiological buffers, 
even in the presence of 8A2 (FauU, R., unpublished obser- 
vations). 
48 h after addition of 100 nM PMA, THP-1 cells bound 
soluble fibronectin with high affanity (Ka  =  10.2 riM)  to 
'~2.7  x  104  binding  sites  per  cell  (Fig.  8).  Again  the 
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Binding of soluble fibronectin to (a) undifferentiated and (b) 
differentiated THP-1 cells is primarily dependent on (x5fll. (a) Fibronectin 
binding to undifferentiated THP-1 cells in the presence or absence of 8A2 
(20 nM), and blocking monodonal antibodies against ot4fll (HP2/1) or 
aSfll (Ab 16). (b) Binding to differentiated THP-1 cells in the presence 
of the same antibodies. Cells were differentiated and the binding of 12Sl- 
labeled soluble fibronectin was determined as described in Materials and 
Methods. The results shown are the estimated specific binding, and are 
the mean  _+  SD of three determinations. 
fibronectin was predominantly bound to o~5fll (Fig.  7 b). 
In the presence of 8A2 (20 riM) the soluble fibronectin was 
bound  with  similar  affinity  (Ka  =  9.34  nM),  but  the 
number of high affinity binding sites increased *3.4-fold (9.4 
x  104 binding sites/cell).  The increase in number of high 
affnity binding sites was highly significant by constrained 
parameter (51) curve fitting (F  =  160.83,  df =  31, P  =  0). 
In contrast, the difference in receptor affnity was not signi- 
ficant (F  =  .16, df =  31, P  =  0.692). At higher input con- 
centrations of radiolabeled fibronectin, binding to a separate 
population of low affinity receptors could also be detected 
(not shown). The 8A2-induced binding of fibronectin was 
still predominantly to ot5fll rather than to another receptor 
(Fig.  7 b). The 8A2 had no significant effect on the number 
of aSfll receptors expressed on the cell surface, as determined 
by flow cytometry using  Ab16  (mean fluorescence index 
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Figure 8.  Specific  binding  of increasing concentrations of soluble fibro- 
nectin to differentiated THP-1 cells, either in the presence or absence of 
8A2 (20 nM whole IgG). Cells were differentiated and the binding of 
t2SI-labeted soluble fibronectin was determined as described in Materials 
and Methods.  The results shown are the estimated specific binding. 
without 8A2  =  19.2 and with 8A2  =  20.2;  see Materials 
and Methods). Thus, differentiation of THP-1 cells results 
in  induction  of olSfll  with  high  affinity for fibronectin. 
Nevertheless, ~70% of the c~5fll are still in the low affnity 
state. 
We next used the T lymphoid cell line HUT-78 in order 
to examine the relationship between adhesion to immobi- 
lized fibronectin and binding of soluble fibronectin after cell 
activation by cross-linking the TCK. The HUT-78 cells ex- 
press c~4fll and otSfll as their predominant fibronectin re- 
ceptors, and the ratio of the two is similar to that found on 
peripheral blood T  lymphocytes (Fig.  1). Stimulation with 
either 8A2 or by cross-linking the TCR enhanced HUT-78 
adhesion to fibronectin (Fig.  9 a), and neither stimulus in- 
duced visible changes in cell spreading. The unstimulated and 
stimulated adhesion were blocked by a combination of anti- 
bodies against c~4fll and olSfll, analogous to the Molt-4 cells 
(not shown). Both TCR cross-linking and 8A2 also increased 
the binding of soluble fibronectin to the cells (Fig.  9 b). In 
contrast, PMA had no such effect (data not shown). 
Discussion 
We draw the following conclusions from these experiments: 
(a) T  lymphoid cell adhesion to fibronectin can be stimu- 
lated either by increasing the affinity of fibronectin binding 
to receptors or by altering events that occur following receptor 
occupancy. (b) Increasing the affinity of fibronectin receptors 
in the presence of soluble fibronectin may decrease cell adhe- 
sion. In contrast, postoccupancy mechanisms of increasing 
adhesion are unaffected by soluble fibronectin. (c) Differenti- 
ation of monocytic cells or stimulation of T lymphoid cells 
by cross-linking their TCR induces high affinity binding of 
soluble fibronectin. (d) Differentiated monocytic cells express 
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cell line HUT-78 to immobilized fibronectin and increases  the binding 
of soluble fibronectin. Cell stimulation by cross-linking the TCR was per- 
formed as described  in Materials and Methods. (a) The effects of cross- 
linking the TCIL or 8A2 (20 riM) on the adhesion of HUT-78 cells to 
increasing concentrations of immobilized fibronectin were determined as 
described in Materials and Methods. The results are expressed as the per- 
centage of the cells added to each weU that remain adherent after washing, 
and are the mean _+ SD of three determinations. (b) The effects of cross- 
linking the TCR or 8A2 (20 riM) on the binding of 100 nM 2zSI-labeled 
fibronectin to HUT-78 cells were determined as described in Materials and 
Methods. The results shown are the estimated specific binding, and are 
the mean  _+  SD of three determinations. 
two populations of fibronectin receptors: a minority in a high 
affinity state and the majority in a low afffnity state. Thus 
they will continue to adhere in the presence of physiological 
concentrations of soluble fibronectin. 
Adhesion of T lymphoid cells to fibronectin can be increased 
by two distinct mechanisms. The first is through conversion 
of the receptors to a high affinity form. Secondly, stimuli 
such as PMA enhance adhesion without any measurable change 
in the affinity for soluble fibronectin, and the increase in adhe- 
sion is associated with an increase in cell spreading.  Cyto- 
chalasin D blocked the change in cell shape and also abrogated 
the increased adhesion. The 8A2 and PMA had an additive 
effect on cell adhesion, showing that in situations of lim- 
iting availability of immobilized ligand optimal cell adhe- 
sion requires both high affnity receptors and efficient post- 
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receptor occupancy events. This is analogous to ~Ilbfl3, where 
the "inactive" (low affinity) form is competent for adhesion 
to immobilized fibrinogen (55, 56) but does not bind soluble 
fibrinogen.  Cytoskdetal organization and subsequent cell 
spreading dramatically increase the resistance of cells to shear 
stresses, resulting in stronger adhesion under experimental 
conditions (57-59). Phorbol esters are known to affect these 
events. For example, they stimulate associations between inte- 
grins and the cytoskeleton (60),  and induce shape changes 
in neutrophils (61), and both PMA-induced macrophage adhe- 
sion to laminin (62) and c~Lfl2-mediated intercellular adhe- 
sion (63, 64) are dependent on cytoskdetal assembly. In ad- 
dition, PMA stimulation of adhesion of Chinese hamster ovary 
cells to fibronectin does not depend on an increase in the 
affnity for soluble fibronectin (65). Activation ofT lympho- 
cytes by cross-linking their TCR also stimulates association 
between integrins and the cytoskeleton (66). 
Neverthdess, while brief stimulation of these calls with 
PMA increases their adhesion to fibronectin without activating 
their fibronectin receptors,  it is known that PMA stimula- 
tion induces high affnity forms of the integrins cdlbB3 on 
platelets (24) and olMfl2 on monocytes (25) and neutrophils 
(67). This conformational sensitivity to PMA may be inte- 
grin dependent, and not a general property of all members 
of the family. Alternatively, the effects of PMA may be cell- 
type dependent, and it is significant  that cdlfl3 cannot be 
activated by PMA (or other platelet agonists) when expressed 
by other cells (e.g.,  Chinese hamster ovary cells) (68). 
The net influence of soluble fibronectin on stimulated cell 
adhesion is dependent on the mechanism of stimulation. This 
has potential implications for the regulation of cell adhesion 
in vivo, as cells within the circulation are continuously ex- 
posed to soluble fibronectin at a concentration of 450-900 
nM (69, 70).  Fibronectin is also abundant in the extravas- 
cular fluids, although the concentration has only been mea- 
sured in limited situations (e.g., synovial fluid, amuiotic fluid, 
pleural effusions) (15). At the concentration of soluble fibro- 
nectin used in these experiments (750 nM) there is a modest 
inhibition of unstimulated adhesion due to partial occupancy 
of the low affnity receptors.  The receptors remain in a low 
affinity state in the presence of PMA, so that soluble fibronectin 
also causes modest inhibition. Nevertheless,  there remains 
a clearcut increase in adhesion compared to the unstimulated 
cells. In marked contrast, the 8A2 blocks adhesion, as >90% 
(calculated) of the high affnity receptors are occupied at this 
concentration of soluble fibronectin. Hence, high affnity 
fibronectin receptors do not mediate adhesion in the pres- 
ence of plasma concentrations of soluble fibronectin, sug- 
gesting that they have an alternative function. Interestingly, 
high affnity fibronectin binding occurs almost exclusively 
to c~5fll, and the ot4fll remains a low affinity receptor. There- 
fore c~4fll remains available to mediate cell adhesion to both 
fibronectin and vascular cell adhesion molecule I in the pres- 
ence of soluble fibronectin, and PMA can still increase c~4fll- 
mediated adhesion. This implies that cells use the low affinity 
receptors for adhesion under these circumstances,  and that 
adhesion can still be stimulated by an effect on the post-receptor 
occupancy events. This is analogous to the observation that stiffening of neutrophils,  due to organization  of the cyto- 
skeleton induced by chemoattractants,  may underlie their se- 
questration in lung and other capillaries during acute inflam- 
mation  (71). 
Both of the physiological inducers of high affinity fibro- 
nectin binding that  we have studied are models for events 
that occur as those cell types (monocytes and T lymphocytes) 
become tissue resident during inflammation.  This suggests 
that the high affinity fibronectin receptors have a specific role 
in this process. One possibility is that they promote assembly 
of a fibronectin matrix,  enabling the cells to persist at the 
site of inflammation.  For example, differentiation of F-9 ter- 
atocarcinoma stem cells in culture by retinoic acid is accom- 
panied by the accumulation of fibrillar fibronectin deposits 
(72), suggesting that the fibronectin receptors have become 
competent to bind soluble fibronectin. In contrast, transfor- 
mation of chicken embryo fibroblasts with Rous sarcoma virus 
is associated with loss of cell surface fibronectin and decreased 
interaction of the receptors with talin and fibronectin (73, 74). 
The heterogeneity of the c~5B1 on the differentiated  THP-1 
cells suggests that  it is important  that  the cells maintain  a 
population of low affinity c~5B1 receptors, possibly for adhe- 
sion and subsequent detachment during cell migration. Evi- 
dence for functional heterogeneity of integrins has been re- 
ported  in  other  studies.  For  example,  cultured  human 
endothelial cells express integrins (including c~5~1) on both 
their  basal and luminal  aspects  (75),  but  only assemble a 
fibronectin matrix at their basolateral surfaces. This suggests 
that only the receptors at this site are capable of binding soluble 
fibronectin with high affinity (76).  In another  study,  two 
distinct populations orB1 integrins were identified on chicken 
embryo fibroblasts using a differential extraction procedure 
(77), and the fraction associated with focal contacts exhibited 
significantly higher phosphorylation.  Finally,  heterogeneity 
is not confined to the 81 integrins,  as an active subpopula- 
tion of c~MB2 was defined on neutrophils using a monoclonal 
antibody that  binds  to an activation-specific epitope (67). 
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